Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03699475
Title Study of Haplo-HSCT + BPX-501 vs Haplo-HSCT + Post Transplant Cyclophosphamide in Patients With AML or MDS (THRIVE)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bellicum Pharmaceuticals
Indications

acute myeloid leukemia

myelodysplastic syndrome

Therapies

BPX-501 + Rimiducid

Cyclophosphamide

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.